These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15104342)

  • 1. Does residual volume after drainage matter in peritoneal dialysis treatment?
    Parikova A; Zweers MM; Hiralall JK; Struijk DG; Krediet RT
    Perit Dial Int; 2004; 24(1):75-7. PubMed ID: 15104342
    [No Abstract]   [Full Text] [Related]  

  • 2. Association between peritoneal protein excretion, peritonitis and D/P phosphate, in patients on peritoneal dialysis.
    Rodríguez-García VH; López-Guerra EA; Rodríguez-Castellanos FE
    Nefrologia; 2013; 33(2):204-13. PubMed ID: 23511756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal peritoneum after nine years of peritoneal dialysis with biocompatible dialysate: a case report.
    Kamijo Y; Iida H; Saito K; Furutera R; Ishibashi Y
    Perit Dial Int; 2013; 33(6):712-4. PubMed ID: 24335133
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors increasing severity of peritonitis in long-term peritoneal dialysis patients.
    Park MS
    Adv Ren Replace Ther; 1998 Jul; 5(3):185-93. PubMed ID: 9686629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of biocompatibility in peritoneal dialysis solutions.
    Passlick-Deetjen J
    Perit Dial Int; 1993; 13 Suppl 2():S101-4. PubMed ID: 8399540
    [No Abstract]   [Full Text] [Related]  

  • 6. What are the problems with using the peritoneal membrane for long-term dialysis?
    Bargman JM; Krediet RT; Lo WK; Selgas R; del Peso G; Auxiliadora Bajo M; Mujais S
    Semin Dial; 2008; 21(1):11-23. PubMed ID: 18251949
    [No Abstract]   [Full Text] [Related]  

  • 7. The Trio Trial - A Randomized Controlled Clinical Trial Evaluating the Effect of a Biocompatible Peritoneal Dialysis Solution on Residual Renal Function.
    Sikaneta T; Wu G; Abdolell M; Ng A; Mahdavi S; Svendrovski A; Tu T; Mercer T; Tong M; Oreopoulos D; Tam P
    Perit Dial Int; 2016 9-10; 36(5):526-32. PubMed ID: 27282852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up of peritoneal clearances in patients undergoing continuous ambulatory peritoneal dialysis.
    Rubin J; Nolph K; Arfania D; Brown P; Prowant B
    Kidney Int; 1979 Nov; 16(5):619-23. PubMed ID: 548605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent concepts in the molecular biology of the peritoneal membrane - implications for more biocompatible dialysis solutions.
    Mortier S; De Vriese AS; Lameire N
    Blood Purif; 2003; 21(1):14-23. PubMed ID: 12566656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resumption of peritoneal dialysis after transcutaneous treatment of a peritoneal leakage using fibrin glue.
    Herbrig K; Pistrosch F; Gross P; Palm C
    Nephrol Dial Transplant; 2006 Jul; 21(7):2037-8. PubMed ID: 16520352
    [No Abstract]   [Full Text] [Related]  

  • 11. Membrane transport status does not predict peritonitis risk in patients on peritoneal dialysis.
    So S; Aw L; Sud K; Lee VW
    Nephrology (Carlton); 2018 Jul; 23(7):633-639. PubMed ID: 28437596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CARI guidelines. Evidence for peritonitis treatment and prophylaxis: the influence of peritoneal dialysis systems and solutions on the incidence of peritonitis and catheter-related infections.
    Caring for Australians with Renal Impairment (CARI)
    Nephrology (Carlton); 2004 Oct; 9 Suppl 3():S41-4. PubMed ID: 15469555
    [No Abstract]   [Full Text] [Related]  

  • 13. The Clinical Course and Peritoneal Function in a Patient Under Peritoneal Dialysis for Over 30 Years.
    Ko SH; Ng YY
    Perit Dial Int; 2017 Jan; 37(1):123-124. PubMed ID: 28153973
    [No Abstract]   [Full Text] [Related]  

  • 14. Clear peritoneal effluent in a child on CCPD with a phlegmonous appendicitis.
    Horuz F; Sleeboom C; Bouts AH; Davin JC; Groothoff JW
    Pediatr Nephrol; 2005 Oct; 20(10):1504-5. PubMed ID: 15965769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic peritoneal dialysis in iron-deficient rats with solutions containing iron dextran.
    Reddy DK; Moore HL; Lee JH; Saran R; Nolph KD; Khanna R; Twardowski ZJ
    Kidney Int; 2001 Feb; 59(2):764-73. PubMed ID: 11168960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of duration of peritoneal dialysis therapy on the outcomes of initial and subsequent peritonitis is different.
    Xu R; Chen Y; Luo S; Li Y; Dong J
    Perit Dial Int; 2012; 32(4):473-6. PubMed ID: 22859843
    [No Abstract]   [Full Text] [Related]  

  • 17. Strategy for preventing peritoneal dialysis failure.
    Cancarini G
    Contrib Nephrol; 2001; (131):114-24. PubMed ID: 11125557
    [No Abstract]   [Full Text] [Related]  

  • 18. [Peritoneal dialysis].
    Ryckelynck JP; Lobbedez T; Hurault de Ligny B
    Nephrol Ther; 2005 Oct; 1(4):252-63. PubMed ID: 16895693
    [No Abstract]   [Full Text] [Related]  

  • 19. Peritoneal defense mechanisms--the effects of new peritoneal dialysis solutions.
    Kazancioglu R
    Perit Dial Int; 2009 Feb; 29 Suppl 2():S198-201. PubMed ID: 19270217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biocompatible dialysis fluids for peritoneal dialysis.
    Cho Y; Johnson DW; Craig JC; Strippoli GF; Badve SV; Wiggins KJ
    Cochrane Database Syst Rev; 2014 Mar; (3):CD007554. PubMed ID: 24671928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.